In a report released today, Cecilia Furlong from Morgan Stanley maintained a Buy rating on Boston Scientific (BSX – Research Report), with a price target of $46.00. The company's shares closed last Friday at $37.41. According to TipRanks.com, Furlong is a 4-star analyst with an average return of 19.6% and a 45.2% success rate. Furlong covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Bausch + Lomb Corporation, and Irhythm Technologies. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Boston Scientific with a $47.46 average price target, implying a 27.3% upside from current levels.
https://www.tipranks.com/news/blurbs/morgan-stanley-keeps-a-buy-rating-on-boston-scientific-bsx?utm_source=advfn.com&utm_medium=referral
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Sep 2022 to Oct 2022 Click Here for more Boston Scientific Charts.
Boston Scientific (NYSE:BSX)
Historical Stock Chart
From Oct 2021 to Oct 2022 Click Here for more Boston Scientific Charts.